Further, a large cohort-study demonstrated that the levels of circulating progenitor cells (PCs) (CD34+/CD34+ KDR+) could be used as predictors of the development of PAD in patients with known CAD, being DM a risk factor in the development of PAD in these patients [137]. This evidence concerns the gene CD34 and coronary artery disorder.